Received Sep 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | IM |
diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 73-year-old male patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On 16-Sep-2025, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) was resolving. No concomitant medication was reported. The patient had diarrhea which started 4 hours after administering vaccine. It was unknown if the patient experienced any additional symptoms or events. Reporter causality was not provided. No treatment medication was reported.